Page 4 - Nasdaq Ikna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ikna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ikna Today - Breaking & Trending Today

Short Interest in Ikena Oncology, Inc. (NASDAQ:IKNA) Declines By 22.9%

Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 215,300 shares, a decrease of 22.9% from the May 31st total of 279,400 shares. Currently, 1.0% of the company’s stock are sold short. Based […] ....

United States , Virtu Financial , Dimensional Fund Advisors , Jpmorgan Chase Co , Ikena Oncology Company Profile , Ikena Oncology Inc , Credit Suisse Group , Cubist Systematic Strategies , Millennium Management , Ikena Oncology , Free Report , Fund Advisors , Systematic Strategies , Suisse Group , Ikena Oncology Daily , Nasdaq Ikna ,

Ikena Oncology, Inc. (NASDAQ:IKNA) to Post Q1 2023 Earnings of ($0.41) Per Share, HC Wainwright Forecasts

Ikena Oncology, Inc. (NASDAQ:IKNA – Get Rating) – Equities research analysts at HC Wainwright issued their Q1 2023 earnings per share estimates for Ikena Oncology in a report released on Thursday, May 4th. HC Wainwright analyst A. Maldonado anticipates that the company will earn ($0.41) per share for the quarter. HC Wainwright has a “Buy” […] ....

Citadel Advisors , Vanguard Group Inc , Ikena Oncology Inc , Blackrock Inc , Ikena Oncology Company Profile , Verition Fund Management , Credit Suisse Group , Ikena Oncology , Get Rating , Suisse Group , Fund Management , Vanguard Group , Ikena Oncology Daily , Nasdaq Ikna , Earnings Estimates , Hc Wainwright ,

HC Wainwright Reiterates Buy Rating for Ikena Oncology (NASDAQ:IKNA)

HC Wainwright reiterated their buy rating on shares of Ikena Oncology (NASDAQ:IKNA – Get Rating) in a research report sent to investors on Thursday, MarketBeat reports. HC Wainwright currently has a $18.00 price objective on the stock. Separately, Credit Suisse Group cut their price objective on shares of Ikena Oncology from $16.00 to $13.00 and […] ....

Ikena Oncology Inc , Credit Suisse Group , Ikena Oncology Company Profile , Charles Schwab Investment Management Inc , Millennium Management , Blackrock Inc , Jpmorgan Chase Co , Goldman Sachs Group Inc , Ikena Oncology , Get Rating , Suisse Group , Schwab Investment Management , Sachs Group , Ikena Oncology Daily , Nasdaq Ikna , Reiterated Rating , Hc Wainwright ,

Ikena Oncology, Inc. (NASDAQ:IKNA) Short Interest Up 33.2% in April

Ikena Oncology, Inc. (NASDAQ:IKNA – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 465,600 shares, a growth of 33.2% from the March 31st total of 349,500 shares. Approximately 1.8% of the shares of the stock are sold short. Based on […] ....

Ikena Oncology Inc , Virtu Financial , Millennium Management , Cubist Systematic Strategies , Credit Suisse Group , Dimensional Fund Advisors , Jpmorgan Chase Co , Ikena Oncology , Get Rating , Suisse Group , Fund Advisors , Systematic Strategies , Ikena Oncology Daily , Nasdaq Ikna ,

Critical Review: Ikena Oncology (NASDAQ:IKNA) & Icosavax (NASDAQ:ICVX)

Ikena Oncology (NASDAQ:IKNA – Get Rating) and Icosavax (NASDAQ:ICVX – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Risk and Volatility Ikena Oncology has a beta of 0.75, […] ....

United States , Ikena Oncology Inc , Icosavax Inc , Ikena Oncology , Get Rating , Given Icosavax , Ikena Oncology Daily , Nasdaq Ikna , Stock Comparison , Stock Analysis ,